Skip to main content
Caplight Logo









Acurable

Acurable

Private
LondonHealthcare & Life Scienceshttps://acurable.com

Last Round

Series A

Oct 3, 2022

Total Funding Raised

$15.28M

Company Overview

Acurable operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Series A round in October 2022.

Acurable is a healthtech company that develops wearable physiological monitoring devices for at-home detection and management of chronic health conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Medical AI, Telemedicine

Business Model

B2B

Customer Profile

Usage-Based SaaS, Hardware Sales

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Acurable Comparables

Compare Acurable with similar companies based on industry and business-model similarity.

Acurable comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Wesper
88%
SleepImage
86%
Onera
85%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Acurable Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AOct 3, 2022
GrantFeb 1, 2019
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Acurable Investors

Notable investors and investment history

Acurable investors
InvestorRounds
Mundi VenturesSeed, Series A
Comprador HoldingsSeries A
Kibo VenturesSeries A
Innovate UKGrant
Kindred CapitalSeed, Series A
Meridian Health VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 3, 2022

    $11M round led by Kibo Ventures

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • recognized_asSep 21, 2026

    TIME magazine names Acurable as one of just two companies from the United Kingdom in its Medical Devices & Wearables category for the World’s Top HealthTech Companies of 2026 list.

Book a demo to see all news

For institutional investors. Book with your work email.

Acurable Filings

Explore SEC and related filing metadata, where available.

Acurable filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Acurable's valuation, stock price, and market status.

Is Acurable a public or private company?

Acurable is a private company.

What is the current stock price of Acurable?

Acurable is a private company, so its shares have no public market price. Caplight tracks Acurable's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Acurable worth (valuation)?

Valuation information for Acurable is not publicly available.

Can I buy Acurable stock?

Acurable shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Acurable's last funding round?

Acurable's most recent funding round was Series A on October 3, 2022.

Who are the main investors in Acurable?

Key investors in Acurable include Kibo Ventures.

Will Acurable IPO soon?

No public IPO plans have been announced for Acurable.

How can I track Acurable secondary market activity?

Caplight tracks bids, offers, and trades in Acurable's shares on secondary markets.

Firmographic Details

HeadquartersLondon
Employee Range23
Year Founded2016
Last FundingOct 3, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?